Segment Information (Tables)

3 Months Ended

Mar. 31, 2018

Selected financial info by reportable segment

Selected financial information by reportable segment is presented below (in thousands):



	Three Months Ended March 31,
	2018			2017
Revenues, net:
Prescription Pharmaceuticals	$	164,302		$	237,379
Consumer Health	19,761			16,041
Total revenues, net	184,063			253,420

Gross Profit:
Prescription Pharmaceuticals	73,508			140,956
Consumer Health	8,720			7,813
Total gross profit	82,228			148,769

Operating expenses	107,643			74,356

Operating (loss) income	(25,415		)	74,413
Other expenses, net	(10,612		)	(9,087		)

(Loss) Income before income taxes	$	(36,027	)	$	65,326

Revenue from External Customers by Geographic Areas

The following table sets forth the Company’s net revenues by geographic region for the three month periods ended March 31, 2018 and 2017. The Domestic region represents sales within the United States of America ("U.S.") and its territories while the Foreign region represents sales within all other countries and territories (dollar amounts in thousands):



	Three Months Ended March 31, 2018			Three Months Ended March 31, 2017
Region	Amount		% of Total Revenues	Amount		% of Total Revenues
Domestic	$	181,015	98.3%	$	245,703	97.0%
Foreign	3,048		1.7%	7,717		3.0%
Total Revenues	$	184,063	100.0%	$	253,420	100.0%